Optimal Antithrombotic Regimen in Left Atrial Appendage Occlusion: The Gordian Knot?

Area of Science:

• Cardiology
• Medical Devices
• Thrombosis

Background:

• Percutaneous left atrial appendage occlusion (LAAO) offers stroke risk reduction for patients with atrial fibrillation and high bleeding risk.
• Device-related thrombosis (DRT) is a significant complication following LAAO procedures.
• Variations in DRT incidence across studies suggest potential influences from antithrombotic regimens and occluder devices.

Discussion:

• A comparative analysis of DRT incidence revealed significant differences: 25.3% in the DRT study, 3.8% in the Amplatzer IDE trial, and 3.3% in the Düsseldorf LAAO registry.
• Antithrombotic strategies differed, with oral anticoagulation more common in the DRT study and dual antiplatelet therapy more prevalent in the Düsseldorf registry.
• The Amplatzer Amulet device was used more frequently in the Düsseldorf registry compared to the DRT study, suggesting a potential device-related factor.

Key Insights:

• DRT incidence is substantially lower with the Amplatzer Amulet device compared to other devices in the analyzed studies.
• The choice of antithrombotic treatment (oral anticoagulation vs. dual antiplatelet therapy) appears to correlate with DRT rates.
• These findings highlight the complex interplay between LAAO devices, antithrombotic therapy, and the risk of device-related thrombosis.

Outlook:

• Further clinical trials are essential to definitively establish the impact of specific LAAO devices and antithrombotic regimens on DRT.
• Optimizing antithrombotic protocols and device selection could mitigate the risk of DRT, improving patient outcomes after LAAO.
• Understanding these factors is crucial for refining LAAO procedures and reducing stroke risk in vulnerable patient populations.